Doximity (DOCS) EBITDA (2020 - 2026)

Doximity (DOCS) has reported EBITDA for 7 consecutive years, with $33.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA fell 38.29% year-over-year to $33.6 million in Q2 2026; TTM through Jun 2026 was $194.0 million, a 17.87% decrease from a year earlier, with the FY2026 full-year figure at $214.9 million, down 5.65% from the prior year.
• EBITDA was $33.6 million for Q2 2026 at Doximity, up from $24.8 million in the prior quarter.
• Over five years, EBITDA peaked at $79.9 million in Q4 2024 and troughed at $21.7 million in Q2 2022.
• A 5-year average of $44.1 million and a median of $40.2 million in 2022 frame the typical range for EBITDA.
• Across the five-year window, EBITDA soared 57.26% in 2024 and slumped 49.0% in 2026, its largest moves.
• Over 5 years, EBITDA stood at $38.5 million in 2022, then jumped by 52.14% to $58.6 million in 2023, then surged by 36.5% to $79.9 million in 2024, then declined by 10.05% to $71.9 million in 2025, then tumbled by 53.2% to $33.6 million in 2026.
• The last three EBITDA figures came in at $33.6 million (Q2 2026), $24.8 million (Q1 2026), and $71.9 million (Q4 2025), per Business Quant data.